The government must prioritise research into new drugs, rather than relying on interventions first made available 60 years ago, writes Marjorie Wallace of Sane

It is not only veterans and emergency workers living with post-traumatic stress disorder who could benefit if ministers heed the call from Sir Nick Carter (Ex-British army chief calls on ministers to back MDMA-assisted therapy for veterans, 1 February). Thousands of people who have major mental illness, and those dealing with bereavement and trauma, could be helped too.

The shocking lack of progress in developing transformative psychiatric medicines, and a dearth of innovation has left clinicians with few weapons in their armoury to relieve mental pain. Families and people scarred by long-term distress tell us they are desperate for new treatments and therapies.

Continue reading…